Bromocriptine Mesylate

AGONISTS

Product Details

CAT No.# CS-I-00026
Category Agonists
CAS 22260-51-1
Molecular Weight 750.7
Molecular Formula C33H44BrN5O8S
Stock Status: In-Stock   View COA
Purity: >98%
Synonyms: (6aR,9R)-5-bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide methanesulfonate
References: Ptácek,R.,et al.:Med Sci Monit.17,RA215(2011); Lieberman,A.N.and Goldstein,M.:Pharmacol Rev. 37,217(1985); Nazli,K.,et al.:Br J Clin Pract.43,322(1989)
Shipping: Free Shipping for worldwide on order above 2000 USD
Bromocriptine Mesylate Worldwide Suppliers of Bromocriptine Mesylate Agonists Clearsynth CS-I-00026

Product rating: 9 Bromocriptine Mesylate based on 20 ratings

  1. Agonists
  2. Bromocriptine Mesylate

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Crisaborole m-Isomer
15. Riluzole (1604337)
16. Pheniramine impurity B
17. Palbociclib N-Glucuronide
18. Carpropamid
19. Olmesartan N1-Trityl Impurity
20. Aripiprazole (1042634)


Smileys:
C[S](=O)(O)=O.O[C@@]([C@@](CCC1)([H])N1C2=O)(O[C@@]3(C(C)C)NC([C@@H](CN(C)[C@]4([H])C5)C=C4C6=C7C5=C(Br)NC7=CC=C6)=O)N([C@H]2CC(C)C)C3=O



This page contains information about Bromocriptine Mesylate Cas 22260-51-1 and its Agonists.

Bromocriptine Mesylate Bromocriptine Mesylate Worldwide Suppliers of Bromocriptine Mesylate Agonists Clearsynth 22260-51-1

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."